Axys Pharmaceuticals, Inc. to Release / Webcast Fourth Quarter & Year-End 2000 Financials Results Thursday, March 8, 2001.

Business Editors & Health/Medical Writers

SOUTH SAN FRANCISCO, Calif.--(BW HealthWire)--Feb. 26, 2001

Axys Pharmaceuticals (Nasdaq: AXPH) today said that its fourth quarter and year-end 2000 financial results will be released on Thursday, March 8th at 8:30 a.m. Eastern Standard Time (EST), or 5:30 a.m. Pacific Standard Time (PST).

At 10:00 a.m. EST, or 7:00 a.m. PST, as part of the Company's efforts to ensure full disclosure to all parties, Axys will webcast a conference call live on the Company's internet site. Hosting the call will be Paul J. Hastings, President and Chief Executive Officer.

To access the live call or the 5-day archive, please log onto http://www.axyspharm.com. Alternatively, the webcast may be accessible by logging onto http://www.vcall.com/NASApp/Vcall/consoleframeset2?ID=68600. Please connect to either website at least 10 minutes prior to the conference call to ensure adequate time for any software download that may be needed to hear the live webcast.

Axys Pharmaceuticals, Inc. an integrated small molecule drug discovery and development company, has a broad pipeline of products for chronic therapeutic applications that are partnered with world-class pharmaceutical companies and a proprietary product portfolio in oncology. Axys is also building shareholder value through minority investments in affiliated businesses that leverage the Axys technologies. Currently, these companies include Discovery Partners International (Nasdaq: DPII) a chemistry services company; DNA Sciences, a genetics company; and Akkadix Corporation, an agricultural biotechnology company.

For more information about Axys Pharmaceuticals, Inc., please visit the company's website at http://www.axyspharm.com.